Effects of inhibitors of the chemokine receptor CXCR4 on acute lymphoblastic leukemia cells in vitro (Q73595089)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12835717%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

Effects of inhibitors of the chemokine receptor CXCR4 on acute lymphoblastic leukemia cells in vitro (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12835717%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

main subject

lymphoblastic leukemia

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12835717%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

J Juarez

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12835717%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

K F Bradstock

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12835717%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

L J Bendall

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12835717%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 July 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12835717%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12835717%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12835717%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12835717%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

1294-1300

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12835717%20AND%20SRC:MED&resulttype=core&format=json

Effects of the chemokine stromal cell-derived factor-1 on the migration and localization of precursor-B acute lymphoblastic leukemia cells within bone marrow stromal layers.

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402998

7 January 2021

Molecular cloning and structure of a pre-B-cell growth-stimulating factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402998

7 January 2021

Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402998

7 January 2021

Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402998

7 January 2021

The chemokine receptor CXCR4 enhances integrin-mediated in vitro adhesion and facilitates engraftment of leukemic precursor-B cells in the bone marrow.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402998

7 January 2021

Survival of human leukaemic B-cell precursors is supported by stromal cells and cytokines: association with the expression of bcl-2 protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402998

7 January 2021

N-terminal peptides of stromal cell-derived factor-1 with CXC chemokine receptor 4 agonist and antagonist activities

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402998

7 January 2021

A Small Molecule CXCR4 Inhibitor that Blocks T Cell Line–tropic HIV-1 Infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402998

7 January 2021

Effective lowly cytotoxic analogs of an HIV-cell fusion inhibitor, T22 ([Tyr5,12, Lys7]-polyphemusin II).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402998

7 January 2021

Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402998

7 January 2021

Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402998

7 January 2021

AMD3100, a potent and specific antagonist of the stromal cell-derived factor-1 chemokine receptor CXCR4, inhibits autoimmune joint inflammation in IFN-gamma receptor-deficient mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402998

7 January 2021

Chemokines and the molecular basis of cancer metastasis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402998

7 January 2021

The chemokine SDF‐1, stromal cell‐derived factor 1, attracts early stage B cell precursors via the chemokine receptor CXCR4

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402998

7 January 2021

Maturation decreases responsiveness of human bone marrow B lineage cells to stromal-derived factor 1 (SDF-1)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402998

7 January 2021

SDF-1-induced actin polymerization and migration in human hematopoietic progenitor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402998

7 January 2021

Enhancement of intracellular signaling associated with hematopoietic progenitor cell survival in response to SDF-1/CXCL12 in synergy with other cytokines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402998

7 January 2021

Development of specific CXCR4 inhibitors possessing high selectivity indexes as well as complete stability in serum based on an anti-HIV peptide T140.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402998

7 January 2021

Antiviral efficacy in vivo of the anti-human immunodeficiency virus bicyclam SDZ SID 791 (JM 3100), an inhibitor of infectious cell entry

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402998

7 January 2021

AMD3100, a CxCR4 antagonist, attenuates allergic lung inflammation and airway hyperreactivity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402998

7 January 2021